HIGHLIGHTS
- who: Chunjian Zuo and colleagues from the China Medical University, China have published the research: Polymorphisms in ERCC4 and ERCC5 and risk of cancers: Systematic research synopsis, meta-analysis, and epidemiological evidence, in the Journal: (JOURNAL) of 30/08/2021
- what: Ineligible studies were excluded for these reasons: studies researched the association between polymorphisms of other subgroup genes of ERCC and cancer risk; metaanalyses, systematic reviews, pooled analyses, and duplicated publications; adequate data (e_g, the amount of genotype) could not be acquired; and_(4) studies focused only on the prognosis and survival of cancer patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.